T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.49B |
| 2 |
Micron Technology
MU
|
+$6.62B |
| 3 |
Lam Research
LRCX
|
+$3.45B |
| 4 |
Applied Materials
AMAT
|
+$3.03B |
| 5 |
Advanced Micro Devices
AMD
|
+$2.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.1B |
| 2 |
Apple
AAPL
|
+$11.6B |
| 3 |
Amazon
AMZN
|
+$3.54B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.07B |
| 5 |
Keysight
KEYS
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.73% |
| 2 | Healthcare | 11.3% |
| 3 | Financials | 10.32% |
| 4 | Communication Services | 9.66% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Ford
F
$49.5B
| $79.2M | 0.01% |
5,696,373
+118,624
| +2% | +$1.6M |
|
752
XPO
XPO
$20.8B
| $79.2M | 0.01% |
385,684
+208,598
| +118% | +$44.1M |
|
753
Laureate Education
LAUR
$5.18B
| $79M | 0.01% |
2,175,730
+587,390
| +37% | +$19.8M |
|
754
Douglas Emmett
DEI
$1.61B
| $78.3M | 0.01% |
6,637,391
-199,462
| -3% | -$2.24M |
|
755
Harmonic Inc
HLIT
$1.17B
| $78.3M | 0.01% |
4,793,472
+4,665,581
| +3,648% | +$59.5M |
|
756
Regal Rexnord
RRX
$10.4B
| $78.2M | 0.01% |
328,192
+263,931
| +411% | +$55.1M |
|
|
KLRA
757
Kailera Therapeutics
KLRA
$1.45B
| $77.9M | 0.01% |
+3,534,410
| New | +$77.7M |
|
|
FRVO
758
Fervo Energy
FRVO
$4.22B
| $77.7M | 0.01% |
+2,658,721
| New | +$96M |
|
759
Anterix
ATEX
$1.6B
| $77.3M | 0.01% |
750,451
+742,496
| +9,334% | +$43.6M |
|
760
Exelon
EXC
$41.6B
| $76.7M | 0.01% |
1,644,347
+80,084
| +5% | +$3.7M |
|
761
Ceco Environmental
CECO
$4.28B
| $75.8M | 0.01% |
835,692
+814,322
| +3,811% | +$64.4M |
|
762
Globus Medical
GMED
$10B
| $75.2M | 0.01% |
951,956
+351,791
| +59% | +$29.9M |
|
763
Coinbase
COIN
$51.3B
| $75.2M | 0.01% |
514,073
-54,026
| -10% | -$9.75M |
|
764
ACM Research
ACMR
$5.31B
| $75.1M | 0.01% |
591,573
+374,618
| +173% | +$26.5M |
|
765
Travere Therapeutics
TVTX
$5.78B
| $74.9M | 0.01% |
1,318,616
+913,811
| +226% | +$40.5M |
|
766
T. Rowe Price Dividend Growth ETF
TDVG
$1.43B
| $74.9M | 0.01% |
1,527,399
+2,398
| +0.2% | +$114K |
|
767
Cabot Corp
CBT
$4.07B
| $74.9M | 0.01% |
824,468
+339,481
| +70% | +$27.8M |
|
768
Ocular Therapeutix
OCUL
$1.75B
| $74.9M | 0.01% |
7,623,533
+1,726,384
| +29% | +$15.6M |
|
769
Axcelis
ACLS
$3.81B
| $74.7M | 0.01% |
394,455
+32,253
| +9% | +$4.78M |
|
770
SSR Mining
SSRM
$6.98B
| $74.4M | 0.01% |
2,629,893
+1,736,573
| +194% | +$52.9M |
|
771
Madison Square Garden
MSGS
$9.94B
| $74.1M | 0.01% |
184,298
-400,305
| -68% | -$142M |
|
772
Perimeter Solutions
PRM
$4.6B
| $73.2M | 0.01% |
2,052,289
+1,892,983
| +1,188% | +$59.1M |
|
773
The Mosaic Company
MOS
$7.07B
| $73.1M | 0.01% |
3,447,391
-2,047,044
| -37% | -$47.3M |
|
774
United States Antimony
UAMY
$648M
| $72.8M | 0.01% |
10,031,734
+9,947,422
| +11,798% | +$90M |
|
775
Galicia Financial Group
GGAL
$6.02B
| $72.7M | 0.01% |
1,452,595
-314,857
| -18% | -$14.8M |
|
Similar funds
T. Rowe Price Associates's Q2 2026 Portfolio in Review
As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
- T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
- T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
- T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
- T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
- T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.